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Abstract 
Graphene oxide modified screen-printed electrodes have been tested as amperometric sensors for 
morphine determination. The results demonstrate that the arising of electrocatalytic processes 
ascribable to the graphene coating, combined with the use of a suitable cleaning procedure, allow 
the sensor to achieve higher sensitivity (2.61 nA ppb
-1
) and lower limit of detection (2.5 ppb) with 
respect to those reported in the literature for similar devices. 
Due to very low detection limit found, the device is suitable to detect the presence of morphine in 
urine samples after a very simple and rapid pre-treatment of the matrix, allowing the removal of 
interfering species affecting the voltammetric responses. Tests performed in synthetic urine samples 
demonstrate that the presence of the electrocatalytic coating is mandatory in resolving the peak due 
to morphine oxidation in respect to uric acid. The sensor proposed is, thus, suitable to detect this 
drug even at concentration values below the cut-off levels defined by European and American 
regulations. These results allow us to propose the sensor for screening tests in portable devices, to 
be applied in systematic controls of drug abuses, e.g. in drivers and in men at work. 
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1. Introduction 
Morphine is a highly effective drug for the treatment of severe pains, because it acts directly on the 
central nervous system, where it mimics the effects of the endorphins, i.e. endogenous 
neuropeptides possessing powerful analgesic and exciting activity. 
It is extracted for opium poppy straw. The yearly production worldwide is estimated to more than 
five hundred tons [1]. Only ten percent of morphine produced is directly used in pain therapies, with 
an increase of more than four times over the last twenty years. The most part of morphine, in fact, is 
used as the starting compound for the synthesis of other opioids, such as hydromorphone, 
oxymorphone and heroin, whose analgesic effect and addiction are so strong to be considered as 
drugs of abuse [1-3]. On the other hand, morphine itself is also considered an illicit drug, exhibiting 
potentially serious side effects, such as slow respiratory rate and low blood pressure, and constitutes 
an indicator of abuse of other opioids, being one of their metabolites [4]. 
Due to all these effects, this analyte requires to be strictly monitored in many environmental and 
biological samples. Low detection and quantification limits are necessary to define the path 
followed by morphine after assumption, to assess its presence in the environment, as well as to give 
answer to problems arising in different frames of forensic sciences. 
As a consequence of the importance of morphine detection for human health and for identification 
of opiates abuse, many quantitative analytical methods have been developed. They mainly consist 
of gas chromatography with mass spectrometric detection [5-7] or of liquid chromatographic 
techniques [8,9]. These analyses not only require suitable laboratory equipment, sample pre-
treatments and qualified personnel, but are also time consuming. Although these techniques are 
mandatory for the quantification of morphine in the case of legal controversies [10,11], they are not 
practical for a first screening of the population in systematic controls. For instance, the check of the 
possible occurrence of drug abuses, e.g. by drivers directly on the road or by workers at job, may 
require fast routine controls. Such a control strategy can be only adopted by using portable sensing 
systems equipped by disposable sensor probes. By following this approach, the sensor system may 
not be required to actually quantify drugs, but, rather, to identify subjects under potential altered 
state to select them for a further evaluation in a clinical laboratory. It should lead to an as low as 
possible number of false negatives, i.e. of responses that are erroneously estimated to be within the 
noise confidence interval, whereas a limited number of false positives does not constitute a serious 
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drawback. 
Several progresses along this direction have been recently made by the development of 
amperometric sensors, which base the detection on the occurrence of electrochemical oxidation of 
morphine. Morphine oxidation occurs by one electron charge transfer to the phenoxide ion at the 3-
position, followed by dimerization of the free radical to pseudomorphine [4,12-14]. Two additional 
anodic responses are observed at higher potentials, consisting in the further oxidation of 
pseudomorphine and in the two-electron oxidation of the tertiary amine group. While morphine is 
oxidised at relatively low potentials, most of the other opiates, not possessing phenol groups in the 
molecule, are only oxidisable at higher potentials. This peculiarity has been exploited for the 
selective determination of morphine in samples also containing different opiates, namely codeine, 
heroine and noscapine [15-18]. 
Despite the number of amperometric sensors developed so far for the analysis of morphine (see 
Table 1), none of them was tested for morphine detection in biological fluids at the cut-off limits. In 
any case, the presence of a suitable coating modifying the electrode surface may induce 
electrocatalytic properties that on the one hand anticipates the signal of the analyte and, on the other 
hand, increases the sensitivity of detection [19,20]. However, adsorption phenomena, generally 
occurring as a consequence of the oxidation of a phenol [21,22], constitute eventual major obstacle 
for the actual efficiency of amperometric sensors for morphine detection. 
In this paper, screen-printed electrode (SPE) modified by a graphene oxide coating has been tested 
as an amperometric sensor for morphine. Based on our previous studies concerning the performance 
of this kind of nanosized material [23], electrochemically exfoliated graphene oxide (EGO) has 
been used as the electrode coating. At variance with different graphene oxide materials, it possesses 
appropriate density of oxidised functional groups on the surface to be conductive without the need 
of any reduction pre-treatment. We could prove here that the EGO coating induces anticipation of 
the electrochemical response due to morphine oxidation with respect to bare SPE, leading to higher 
sensor sensitivity and lower detection limit. The analytical performance of this modified electrode 
was defined by tests in standard solutions only containing this species in order to be compared with 
that of different amperometric devices reported by the literature. 
Due to particularly good results found, this sensor was tested for the possible detection of morphine 
in urine samples at concentration values close to the cut-off limits defined for the screening tests in 
urine samples, ranging from 300 ppb in several European countries [10] to 2000 ppb in USA [11]. 
Experiments performed in synthetic urine samples allowed us to put in light, once more, the 
advantage in the use of EGO modified electrodes for the detection of morphine in the presence of 
uric acid, constituting an electroactive component of this matrix. Finally, screening tests of 
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morphine in the real matrix were found possible after the development of a very rapid and 
automatable sample pre-treatment. 
 
 
2. Materials and methods 
 
2.1 Instruments and electrodes  
All electrochemical measurements were performed using a computerized Autolab PGSTAT 30 
(Ecochemie, Utrecht, The Netherlands). SPEs were acquired from DropSens (Llanera, Asturias, 
Spain) and consisted of a 4 mm diameter graphite working electrode, a graphite auxiliary electrode 
and an Ag pseudo-reference electrode. The surface of the working electrode was prepared by 
dropping 6 μL of 0.5 gL−1 EGO dispersion in isopropylic alcohol (IPA), obtained from graphite 
according to the method previously reported [23,37]. The solvent was allowed to evaporate at room 
temperature. The amount of EGO finally present on each electrode was 0.020 mgcm-2. As 
previously defined [23], the amount of material deposited is enough to achieve complete coverage 
of the electrode surface, but not to induce significant variation of the electroactive surface area. 
After deposition, the working electrode was submitted to five subsequent cyclic voltammetric (CV) 
sweeps between 0.00 and +0.60 V, at 0.05 Vs
-1
 potential scan rate, in 0.1 M phosphate buffer 
solution (PBS). The device is now considered ready for morphine detection. 
 
2.2 Morphine detection in buffer solutions 
All reagents, morphine included, were of analytical grade and supplied by Sigma-Aldrich. 
Deionised water (18 M·cm) was always used. Standard solutions of morphine were prepared in 
PBS, at pH 7.0. All solutions used for electrochemical tests with SPEs, even when not specified, 
also contain 0.1 M KCl to fix the potential of the reference electrode. 
Preliminary tests on morphine oxidation at bare and at modified electrode surfaces were carried out 
by CV in a 0.16 mM morphine solution, performing five subsequent potential scans between 0.00 
and +0.60 V, at 0.05 Vs
-1
 scan rate. 
The construction of calibration plots for morphine at low concentrations was performed both at bare 
and at EGO modified SPEs, by differential pulse voltammetry (DPV) technique, by scanning the 
electrode potential between +0.10 and +0.50 V, adopting the following waveform parameters: 50 
mV pulse potential, 6 mV step potential, 0.1 modulation time and 0.4 s time elapsed between two 
subsequent pulses. 
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Between two following tests in morphine solutions, the electrode was treated by five CV scans in 
0.1 M KOH, in order to remove products of morphine oxidation strongly adsorbed on the surface. 
Repeatability of the analytical response was tested by performing three following voltammetric tests 
in 30, 60 and 220 ppb morphine solutions with the same EGO/SPE. The value of RSD% finally 
reported is the mean of the RSD values calculated from voltammetric responses recorded in each of 
these solutions. 
As to reproducibility, it was defined by recording voltammetric traces in these same solutions with 
three EGO/SPEs obtained in similar conditions. The value of RSD% finally reported is the mean of 
the RSD values obtained. As further indicator of sensor reproducibility we also compared the slope 
values calculated from calibration plots obtained with three similar EGO/SPEs. 
 
2.3 Morphine detection in synthetic urine 
Analyses of morphine in synthetic urine samples were performed in order to test the possible 
presence of electroactive species interfering with morphine oxidation response. For this reason, a 
chemical composition as close as possible to the real matrix was prepared. In agreement with DIN 
EN 1616:1999 standard procedure, synthetic urine samples where obtained with 25.0 gL
-1
 urea, 9.0 
gL
-1
 KCl, 3.0 gL
-1
 NH4Cl, 3.0 gL
-1
 Na2SO4 •10 H2O, 2.5 gL
-1
 KH2PO4 , 2.5 gL
-1
 K2HPO4, 2.0 gL
-1 
creatinine, and 0.35 gL
-1
 uric acid. The final pH of this solution was 6.6 (0.1).  
Stock solutions of synthetic urine, either containing or not morphine, were diluted five times with 
0.1 M PBS before DPV analyses. Electrochemical tests were performed with waveform parameters 
equal to those previously reported. 
 
2.4 Morphine detection in real samples 
Real samples of urine have been obtained from healthy voluntaries. They were added with an 
amount of morphine suitable to achieve a concentration even lower than the cut-off limit actually 
defined, i.e. 200 ppb. In order to minimize interference effects of different species present in urine 
(discussed in Results and Discussion section) on the electrochemical signal, 10 µL of 12 M HCl 
were added to 400 µL of the sample. The suspension was then filtered through a 0.2 µm syringe 
nylon filter (Whatman) and the filtered solution was diluted with 0.1 M PBS (pH=7.0) to a final 
dilution factor of five, leading to a sample containing a 40 ppb final concentration of morphine. 
Also in these cases the values of the parameters defining the DPV waveform were the same as those 
for standard solutions in pure PBS. 
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3. Results and Discussion 
 
3.1 Voltammetric detection of morphine in PBS 
The electrochemical behaviour of EGO/SPE has been already tested in the presence of a reversible 
redox species, namely [Fe(CN)6]
2-
 [23]. CV responses evidence that ΔE is similar to that measured 
at bare SPE, indicating a lower resistance of the EGO film with respect to coatings obtained by 
deposition of graphene oxide produced by Hummer method [38], constituting the synthetic 
approach more frequently adopted. Furthermore, voltammetric responses indicate that the presence 
of the nanostructured coating does not modify the total electroactive surface with respect to the 
underlying electrode surface. 
The evaluation of the electrocatalytic behaviour of EGO coatings with respect to morphine 
oxidation was performed by comparing CV traces collected at bare and at modified SPEs, in PBS 
only containing the analyte. As observed in Figure 1, the EGO coating induces a significant 
anticipation of the oxidation peak potential of morphine, from +0.44 V to +0.35 V, with respect to 
the bare electrode. Concurrently, the value of the peak current increases. Both these factors indicate 
the activation of an electrocatalytic process induced by the presence of EGO coating on the 
electrode surface [20,39-41]. 
The advantages described for EGO coatings have been exploited in quantitative analyses performed 
by more sensitive DPV technique. DPV is acknowledged to enhance the signal-to-noise ratio and, 
consequently, to reduce the limit of detection (LOD) with respect to CV; on its turn, it also lowers 
the concentration limit for false negatives [42,43], improving the effectiveness of detection with 
respect to this important issue. 
Aiming at comparing the performance of EGO/SPE with that of similar electrode systems reported 
in the literature (see Table 1), calibration with a single electrode system has been performed, 
calculated on the basis of voltammetric responses collected in solutions at very low concentration of 
morphine (see Figure 2). In order to evidence the possible presence of memory effects, subsequent 
measurements were performed by randomizing the order under which solutions at different analyte 
concentration were analysed. We could observe that quite a good linear correlation between the 
peak intensity and the concentration of morphine was achieved only after the development of a 
cleaning procedure suitable to significantly reduce the effects of surface fouling. As a matter of fact, 
passivation of the electrode surface is not surprising at all, because it resembles what has been 
already evidenced for electrochemical processes involving phenol derivatives [21,22]. Best results 
in terms of repeatability (RSD = 7.2%) were obtained by performing five subsequent CV cycles in a 
strong alkaline solution (0.1 M KOH) between two subsequent DPV analyses. This procedure 
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allows the use of the device for many electrochemical analyses, e.g., in this case, to perform all the 
measurements required to calculate the calibration plot. 
On the other hand, it should be recalled that SPEs are generally used as disposable sensor systems, 
so that the introduction of a proper cleaning step is not required. Obviously, reproducibility is a key, 
mandatory requirement when using similar devices in this frame, since effective comparison with 
standards or between two or more samples is necessary. The reproducibility of the responses 
obtained at EGO/SPEs requires reproducibility of the modification of the electrode surface, which 
was achieved by a suitable stabilisation procedure of the EGO coating, to performed after 
deposition of the electrode coating. We could observe that quite reproducible responses (RSD = 
12%) can be obtained by conditioning a newly realised EGO/SPE with five CV cycles and three 
DPV cycles in 0.1 M PBS. 
The calibration plot finally obtained by combining the results from three EGO/SPEs is reported in 
the inset of Figure 2. The calculated sensor sensitivity, i.e. the slope of the calibration plot, resulted 
2.61(0.09) nA/ppb, that is a value higher with respect to that found for different amperometric 
sensors reported so far by the literature (see Table 1). In this respect, it has to be underlined that 
higher sensitivity values were only found for modified electrodes exploiting adsorptive stripping as 
the detection technique [29,33]. However, this technique requires quite a long pre-concentration 
step under well-controlled stirring of the solution, which constitutes a condition that is not easy to 
adopt in portable and rapid sensor systems. 
The good reproducibility degree of the responses obtained by following the procedure previously 
described was also confirmed by comparison of the calibration plots computed by three different 
EGO modified electrodes (RSD = 5.0%). t-Student test applied to the slope of the three calibration 
plots, considering two of them at a time, demonstrates that the sensitivity of the three similar 
EGO/SPEs is not significantly different, at a confidence level of 95%. 
Measurements at different morphine concentration have been repeated at bare SPEs. In this case, 
the very much lower intensity of the currents forces to only analyse solutions at significantly higher 
concentrations, actually preventing the use of such an electrode for reliable morphine quantification. 
The sensitivity of bare SPEs for morphine detection finally results equal to 0.031(0.001) nA/ppb, 
that is a value significantly lower with respect to that defined for EGO modified SPEs. Since 
measurements previously reported [23] allow us to discard the hypothesis of meaningful differences 
in the electroactive area of the two devices, this result can be only ascribed to the activation of 
electrocatalytic processes and to the arising of peculiar diffusion processes at the EGO 
nanostructured surface [44]. On the other hand, different chemical interactions arising between the 
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analyte and either graphite or graphene surfaces can be also invoked in order to explain the better 
performance of EGO with respect to bare surface. 
The performance of EGO/SPEs for morphine detection was also investigated in order to 
determinate the Limit of Detection (LOD). As suggested by IUPAC [45] and according to a 
criterion adopted in many papers, the lowest signal value detectable is equal to three times the 
standard deviation of the background signal. This value, converted to the relevant concentration by 
exploiting the calibration plot, leads us to calculate a value of 2.5 ppb. This value once more 
demonstrates the good performance of EGO/SPE with respect to similar devices reported in the 
literature (see Table 1). 
On the other hand, a more reliable definition of LOD requires the use of the intercept value of the 
calibration plot and of the relevant standard deviation [43], allowing not to force the noise affecting 
the actual signal to coincide with that in the absence of signal. A LOD of 12.7 ppb was computed 
by following this approach, as the mean value calculated from the three calibration plots obtained at 
different EGO/SPEs. 
As a conclusion of tests in standard water solutions, we can observe that the performance of 
EGO/SPE is significantly better than many similar sensor systems reported in the literature (Table 
1). This result let us envision the possible use of such a sensor in a number of applications. In 
particular, the very low LOD found, well below that of the cut-off limit adopted for screening tests 
of morphine in urine samples [10,11], supports the idea of a possible application of the sensor in 
fast screening tests for the detection of drug abuse. 
 
3.2 Morphine detection in urine samples 
In order to evaluate the possible application of the sensor for morphine detection in urine samples at 
concentration levels as low as the cut-off limits, i.e. 300 ppb, first tests have been carried out in a 
well defined and controlled analytical matrix, namely in a synthetic solution mimicking urine. 
Although literature works generally employ inorganic, electrochemically inert salts to fit the ionic 
strength of urine samples, we choose a more complex composition, also containing organic species 
that are actually present in urine, namely urea, creatinine and uric acid. The final pH of this solution 
is 6.6 (0.1), which is quite close to the value of the physiological matrix. 
NaCl, Na2HPO4, KH2PO4, NH4Cl and Na2SO4 electrochemically inert salts have been used to 
obtain a basic composition for synthetic urine, to which subsequently add the different organic 
species. In this way, we could observe that both creatinine and urea are not electroactive in the 
potential window of interest for morphine oxidation, whereas uric acid leads to an evident peak at 
ca. + 0.25V, at EGO/SPE. Although uric acid is present in urine at a relatively high concentration 
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with respect to morphine, as in the case reported in Figure 3, the oxidation of these two species 
occurs in correspondence to two well separated peaks. In this frame, it should be noticed that the 
five to one dilution factor has been chosen as a compromise between the possibility to retain quite a 
good precision in detecting low morphine concentrations and the minimisation of interference 
effects due to different species present in urine, and particularly of uric acid. 
Based on the curves recorded in the same solutions at a bare electrode, it can be inferred that the 
detection of morphine in this medium is only possible thanks to the activation of electrocatalytic 
processes by EGO films. 
Although a proper definition of a calibration plot in urine samples is not the goal of the use of this 
sensor system, essentially devoted to the development of a “first alarm” sensor system for drug 
abuse, voltammetric traces recorded with the same EGO/SPE at different concentrations of 
morphine (300, 600 and 900 ppb) show a linear dependence of the oxidation peak current of 
morphine, indicating the reliability of this sensor response. 
Furthermore, the possible occurrence of false positive responses was also tested by considering the 
most common pharmaceutical compounds possessing anti-inflammatory and analgesic action 
(paracetamol, acetylsalicylic acid, ibuprofene, ketoprofene, nimesulide), inhibiting stomach acid 
(lansoprazole) and a common benzodiazepine derivative used for treating many disorders, namely 
lorazepam. As also suggested by the literature [46-52], only paracetamol resulted electroactive in 
the potential window used for morphine determination, but gives rise to an oxidation peak at 
different potential, suggesting that false positive results are not obtained from subjects under 
paracetamol administration. 
Thanks to the quite promising results obtained from EGO/SPE in synthetic urine samples, further 
tests have been carried out in real samples. Urine has quite a complex chemical composition so that, 
as expected, by passing from synthetic to real samples the electrochemical signal is affected by 
further interfering species. They constitute minor components of the matrix, but assume importance 
when the signal due to the analyte is extremely low. Particular attention should be directed to 
proteins, to hormones, and to a wide number of metabolites, urobilin included. Due to the presence 
of these components, several sample treatments are proposed by the literature [29,33,35,53], mainly 
based on centrifugation steps. However, this approach requires that the analysis is performed in a 
chemical laboratory. In outlining the procedure to adopt we kept in mind that facile pre-treatment of 
the sample should be adopted in portable detection systems. As already pointed out, at variance 
with reported procedures [29,34], a low dilution factor is required in order to satisfy the goal of the 
paper, i.e. the detection of morphine in urine sample at very low concentration level, namely those 
defined by cut-off limits in European Countries. 
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Best results have been obtained by adding, at first, a suitable amount of concentrated HCl solution, 
to induce protein precipitation and protonation of other organic species containing carboxylic 
moieties. The sample was then filtered in a 0.2 m syringe filter and diluted with 0.1 M PBS, to a 
final dilution factor of five. The final pH of the solution depends on pH of the original sample. 
Figure 4 accounts for different DPV curves recorded on urine samples. A first curve reports a DPV 
response of urine that was simply diluted with PBS solution: the response of uric acid is detectable 
(peak at ca. +0.25V), together with a potentially interfering, low signal at more positive potentials. 
The described pre-treatment of the sample allows the elimination of the species responsible for this 
last signal, so that uric acid is the only electroactive molecule present in the sample at a significative 
concentration. Quite interestingly, analyses of urine samples containing 200 ppb morphine, when 
submitted to the pre-treatment described, let us to record well evident voltammetric signals due to 
morphine oxidation, clearly distinguishable from that of uric acid and from the background (Figure 
4, dotted line). 
 
 
4. Conclusions 
We demonstrate here that EGO-modified SPE constitutes a high performance amperometric sensor 
for morphine quantification, characterised by very higher sensitivity (2.61 nA ppb
-1
) and lower 
detection limit (2.5 ppb) with respect to similar devices proposed so far by the literature. The high 
performance is due to the arising of effective electrocatalytic processes in charge of morphine 
oxidation induced by the presence of a well conductive graphene oxide coating. Furthermore the 
high reproducibility observed allows the possible use of the sensor system as a disposable device, 
even though the good repeatability found in standard solutions induces not to discard the possible 
application of the electrode system in subsequent voltammetric tests after performing the cleaning 
procedure developed. 
Thanks to the performance observed, the device is suitable to be used for morphine screening tests 
in urine samples even when considering concentration values even lower than the cut-off values 
defined by American and European regulations. The development of such a portable and disposable 
sensor system allows us to propose the device for systematic controls of drug abuses, for instance 
by drivers on the streets or by men at work. 
 
 
 
 
11 
 
Acknowledgements 
The research leading to this work was supported by the European Union's Horizon 2020 research 
and innovation programme (grant agreement n°696656 Graphene Flagship) and the EC Marie-Curie 
ITN- iSwitch (GA no. 642196). 
 
  
12 
 
References 
[1] International Narcotics Control Board. https://www.incb.org/documents/Publications/ 
AnnualReports/AR2016/English/AR2016_E_ebook.pdf, 2016 (accessed 4 May 2018) 
[2] G.D.Busse, D.J.Triggle, Morphine, Chelsea House Publishers, New York, 2006. 
[3] S.B. Karch, Drug abuse handbook, 2nd ed.; CRC Press book, Boca Raton, 2006. 
[4] J. M. P. J.Garrido, C. Delerue-Matos, F. Borges, T. R. A. Macedo, A. M. Oliveira-Brett, 
Electrochemical analysis of opiates - an overview, Anal. Lett. 37 (2004) 831 – 844. 
[5] E. J. Cone, W. D. Darwin, Rapid assay of cocaine, opiates and metabolites by gas 
chromatography-mass spectrometry, J. Chromatogr. 580 (1992) 43 – 61. 
[6] R. Wasels, F. Belleville, Gas chromatographic-mass spectrometric procedures used for the 
identification and determination of morphine, codeine and 6-monoacetylmorphine, J. 
Chromatogr. A 674 (1994) 225 – 234. 
[7] M.Y.Salem, S.A.Ross, T.P.Murphy, M.A. El Sohly, GC-MS Determination of Heroin 
Metabolites in Meconium: Evaluation of Four Solid-Phase Extraction Cartridges, J. Anal. 
Toxicol. 25 (2001) 93 – 98. 
[8] M. R. Moeller, S. Steinmeyer, T. Kraemer, Determination of drugs of abuse in blood, J. 
Chromatogr. B, 713 (1998) 91 – 109. 
[9] R. Dams, T.Benijts, W. E. Lambert, A,. P. De Leenheer, J. Chromatogr. B 773 (2002) 53 – 
61. 
[10] European Workplace Drug Testing Society. European Guidelines for Workplace Drug Testing 
in Urine. 2015-11-01 Version 2.0. http://www.ewdts.org/ewdts-guidelines.html, 2015 
(accessed 4 May 2018). 
[11] Department of health and human services. Mandatory guidelines for federal workplace drug 
testing programs. Federal register, 82, 7920 – 7970. https://www.gpo.gov/fdsys/pkg/FR-2017-
01-23/pdf/2017-00979.pdf, 2017. 
[12] J.M.P.J.Garrido, C.Delerue-Matos, F.Borges, T.R.A.Macedo, A.M. Oliveira-Brett, 
Electroanalysis 16 (2004) 1419 – 1426. 
[13] P. H. Jordan, J. P. Hart, Voltammetric behaviour of morphine at a glassy carbon electrode and 
its determination in human serum by liquid chromatography with electrochemical detection 
under basic conditions, Analyst 116 (1991) 991 – 996. 
[14] B. Proksa, L. Molnár, Voltammetric determination of morphine on stationary platinum and 
graphite electrodes, Anal. Chim. Acta 97 (1978), 149 – 154. 
[15] A. Navaee, A.Salimi, H.Teymourian, Graphene nanosheets modified glassy carbon electrode 
for simultaneous detection of heroine, morphine and noscapine, Biosens. Bioel. 31 (2012) 
13 
 
205– 211. 
[16] A. Niazi, J. Ghasemi, M. Zendehdel, Simultaneous voltammetric determination of morphine 
and noscapine by adsorptive differential pulse stripping method and least-squares support 
vector machines, Talanta 74 (2007) 247 – 254. 
[17] M. H. Pournaghi-Azar, A.Saadatirad, Simultaneous voltammetric and amperometric 
determination of morphine and codeine using a chemically modified-palladizedaluminum 
electrode, J. Electroanal. Chem, 624 (2008) 293 – 298. 
[18] A. Salimi, R.Hallaj, G. R.Khayatian, Amperometric detection of morphine at preheated glassy 
carbon electrode modified with multiwall carbon nanotubes, Electroanalysis 17 (2005) 873 – 
879.  
[19] R. Seeber, F. Terzi, C.Zanardi, Functional materials in amperometric sensing: polymeric, 
inorganic, and nanocomposite materials for modified electrodes (Ed. F. Scholz), Springer-
Verlag, Heidelberg, 2014. 
[20] R. Seeber, L.Pigani, F. Terzi, C. Zanardi, Amperometric sensing. A melting pot for material, 
electrochemical, and analytical sciences, Electrochim. Acta 179 (2015) 350 – 363. 
[21] L. Pigani, M. Musiani, C. Pirvu, F. Terzi, C. Zanardi, R. Seeber, Electro-oxidation of 
chlorophenols on poly(3,4-ethylenedioxythiophene)-poly(styrene sulphonate) composite 
electrode, Electrochim. Acta 52 (2007) 1910 – 1918. 
[22] M. A. Heras, S. Lupu, L. Pigani, C. Pirvu, R. Seeber, F. Terzi, C. Zanardi, A poly(3,4-
ethylenedioxythiophene)-poly(styrene sulphonate) composite electrode coating in the 
electrooxidation of phenol, Electrochim. Acta 50 (2005) 1685 – 1691. 
[23] G. Maccaferri, C. Zanardi, Z. Y. Xia, A. Kovtun, A. Liscio, F. Terzi, V. Palermo, R. Seeber, 
Systematic study of the correlation between surface chemistry, conductivity and 
electrocatalytic properties of graphene oxide nanosheets, Carbon 120 (2017) 165 – 175. 
[24] K. C. Ho, C. Y. Chen, H. C. Hsu, L. C. Chen, S. C. Shiesh, X. Z. Lin, Amperometric 
detection of morphine at a Prussian blue-modified indium tin oxide electrode, Biosens. Bioel. 
20 (2004) 3 – 8. 
[25] W. M. Yeh, K. C. Ho, Amperometric morphine sensing using a molecularly imprinted 
polymer-modified electrode, Anal. Chim. Acta 542 (2005) 76 – 82. 
[26] K. C. Ho, W. M.Yeh, T. S. Tung, J. Y. Liao, Amperometric detection of morphine based on 
poly(3,4-ethylenedioxythiophene) immobilized molecularly imprinted polymer particles 
prepared by precipitation polymerization, Anal. Chim. Acta 542 (2005) 90 – 96. 
[27] Y. Zhao, Y. Wu, Y. Zhang, Z. Chen, X. Cao, J. Di, J. Yang, Electrocatalytic behavior and 
amperometric detection of morphine on ITO electrode modified with directly electrodeposited 
14 
 
gold nanoparticles, Electroanalysis 21 (2009) 939 – 943. 
[28] F. Li, J. Song, D. Gao, Q. Zhang, D. Han, L. Niu, Simple and rapid voltammetric 
determination of morphine at electrochemically pretreated glassy carbon electrodes, Talanta, 
79 (2009) 845 – 850. 
[29] F. Li, J. Song, C. Shan, D. Gao, X. Xu, L. Niu, Electrochemical determination of morphine at 
ordered mesoporous carbon modified glassy carbon electrode, Biosens. Bioel. 25 (2010) 1408 
– 1413. 
[30] E. Afsharmanesh, H. Karimi-Maleh, A. Pahlavan, J. Vahedi, Electrochemical behavior of 
morphine at ZnO/CNT nanocomposite room temperature ionic liquid modified carbon paste 
electrode and its determination in real samples, J. Molecular Liquids 181 (2013) 8 – 13. 
[31] A. L. Sanati, H. Karimi-Maleh, A. Badiei, P.Biparva, A. A. Ensafi, A voltammetric sensor 
based on NiO/CNTs ionic liquid carbon paste electrode for determination of morphine in the 
presence of diclofenac, Mater. Sci. Eng. C 35 (2014) 379 – 385. 
[32] Y. Li, L. Zou, Y. Li, K. Li, B. Ye, A new voltammetric sensor for morphine detection based 
on electrochemically reduced MWNTs-doped graphene oxide composite film, Sens. Act. B, 
201 (2014) 511 – 519. 
[33] A. A. Ensafi, M. M. Abarghoui, B. Rezaei, Simultaneous determination of morphine and 
codeine using Pt nanoparticles supported on porous silicon flour modified ionic liquid carbon 
paste electrode, Sens. Act. B219 (2015) 1 – 9. 
[34] N. F. Atta, A. Galal, F. M. Abdel-Gawad, E. F. Mohamed, Electrochemical morphine sensor 
based on gold nanoparticles metalphthalocyanine modified carbon paste electrode, 
Electroanalysis 27 (2015) 415 – 428. 
[35] M. Taeia, F. Hasanpoura, V. Hajhashemi, M. Movahedi, H. Baghlani, Simultaneous detection 
of morphine and codeine in urine samples of heroin addicts using multi-walled carbon 
nanotubes modified SnO2–Zn2SnO4 nanocomposites paste electrode, App. Surf. Sci, 363 
(2016) 490 – 498. 
[36] F. Basiri, M. Taei, Application of spinel-structured MgFe2O4 nanoparticlesfor simultaneous 
electrochemical determination diclofenacand morphine, Microchim.Acta 184 (2017) 155 – 
162 
[37] Z. Y. Xia, G. Giambastiani, C. Christodoulou, M. V. Nardi, N. Koch, E. Treossi, V. Bellani, 
S. Pezzini, F. Corticelli, V. Morandi, A. Zanelli, V. Palermo, Synergic exfoliation of graphene 
with organic molecules and inorganic ions for the electrochemical production of flexible 
electrodes, ChemPlusChem, 79 (2014) 439 – 446. 
[38] S. Park, R. S. Ruoff, Chemical methods for the production of graphenes, Nat. Nanotechnol. 4 
15 
 
(2009), 217-224. 
[39] H. Matsuda, Y.Z. Ayabe, Zurtheorie der Randles-Sevčikschenkathodenstrahl-polarographie, 
Elektrochem. 59 (1955) 494 – 503. 
[40] R. S. Nicholson, I. Shain, Theory of stationary electrode polarography. single scan and cyclic 
methods applied to reversible, irreversible, and kinetic systems, Anal. Chem. 36 (1964) 706 – 
723. 
[41] R.S. Nicholson, Theory and application of cyclic voltammetry for measurement of electrode 
reaction kinetics, Anal. Chem. 37 (1965) 1351 – 1355. 
[42] D. L. Massart, B. G. M. Vandeginste, S. N. Deming, Y. Michotte, L. Kaufman, 
Chemometrics: a textbook. Book series: Data handling in science and technology, B. G. 
M.Vandeginste, L. Kaufman (Eds.), vol. 2. Elsevier, Amsterdam. 1988. 
[43] W. Funk, V. Dammann, G. Donnevert, Quality assurance in analytical chemistry, VCH, 
Weinheim, 1995. 
[44] K. R. Ward, M. Gara, N. S. Lawrence, R. S. Hartshorne, R. G. Compton, Nanoparticle 
modified electrodes can show an apparent increase in electrode kinetics due solely to altered 
surface geometry: the effective electrochemical rate constant for non-flat and non-uniform 
electrode surfaces, J. Electroanal. Chem. 695 (2013) 1 – 9. 
[45] A. D. McNaught, A. Wilkinson, IUPAC. Compendium of Chemical Terminology, 2nd ed. 
(the "Gold Book"). Blackwell Scientific Publications, Oxford. On-line corrected version: 
http://goldbook.iupac.org, 1997 (accessed 4 May 2018). 
[46] S. Kruanetr, P. Pollard, C. Fernandez, R. Prabhu, Electrochemical oxidation of acetyl salicylic 
acid and its voltammetric sensing in real samples at a sensitive edge plane pyrolytic graphite 
electrode modified with graphene  Int. J. Electrochem. Sci. 9 (2014) 5699–5711. 
[47] A. B. Lima, E. O. Faria, R. H. O. Montes, R. R. Cuhna, E. M. Richter, R. A. A. Munoz, W. T. 
P. dos Santos, Electrochemical oxidation of ibuprofen and its voltammetric determination at a 
boron-doped diamond electrode, Electroanalysis 25 (2013) 1585–1588. 
[48] L. Švorca, I. Strežováa, K. Kianičkováa, D. M. Stanković, P. Otřísald, A. Samphao, An 
advanced approach for electrochemical sensing of ibuprofen in pharmaceuticals and human 
urine samples using a bare boron-doped diamond electrode J. Electroanal. Chem. 822 (2018) 
144–152. 
[49] M. Murugananthan, S.S. Latha, G. Bhaskar Raju, S. Yoshihara, Anodic oxidation of 
ketoprofen. An anti-inflammatory drug using boron doped diamond and platinum electrodes, 
J. Hazard. Mater. 2010, 180, 753–758 
[50] S. D. Bukkitgar, N. P. Shetti, R. M. Kulkarni, S. B. Halbhavi, M. Wasim, M. Mylar, P. S. 
16 
 
Durgi, S. S. Chirmure, Electrochemical oxidation of nimesulide in aqueous acid solutions 
based on TiO2 nanostructure modified electrode as a sensor, J. Electroanal. Chem. 778 (2016) 
103–109. 
[51] A. Radi, Anodic voltammetric assay of lansoprazole and omeprazole on a carbon paste 
electrode, J. Pharm. Biomed. Anal. 2003, 31 1007-1012. 
[52] W. F. Smyth, A. Ivaska, A study of the electrochemical oxidation of some 1,4-
benzodiazepines, Analyst, 1985, 110, 1377-1379. 
[53] H. Bagheri, H. Khoshsafar, A. Afkhami, S. Amidi, Sensitive and simple simultaneous 
determination of morphine and codeine using a Zn2SnO4nanoparticle/graphene composite 
modified electrochemical sensor, New J. Chem. 40 (2016) 7102 – 7112. 
  
17 
 
Captions to Figures 
 
Figure 1. Representative CV curves recorded at bare (blue lines) and EGO modified (black lines) 
SPEs in 0.1 M PBS (pH = 7.0) in absence (dotted lines) and in presence (solid lines) of 46 ppm 
(0.16 mM) morphine; 0.05 Vs
-1
 potential scan rate. 
 
Figure 2. DPV responses of EGO/SPE registered in 0.1 M PBS, in presence of morphine, 
subtracted by the background. Inset reports the relevant calibration plot obtained by randomizing 
the concentration of the morphine solutions under analysis and considering responses deriving from 
three different devices. 
 
Figure 3. DPV responses on synthetic urine containing 300 ppb morphine at unmodified (red line) 
and EGO modified (blue solid line) SPEs. As a comparison, the analysis of 300 ppb morphine in 
absence of uric acid is also reported in the case of EGO/SPE (blue dashed line). In all cases, the 
original samples were diluted five times with PBS, so that the signal finally recorded is referred to a 
solution containing 60 ppb morphine and 0.70 gL
-1
 uric acid. 
 
Figure 4. DPV analyses performed with EGO/SPE in urine sample diluted five times with PBS 
before (blue line) and after (black solid line) additional pre-treatment. Black dashed line reports the 
signal recorded for an urine sample containing 200 ppb morphine, after acid pre-treatment and 
dilution as described in the experimental. 
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Caption to Tables 
 
Table 1 - Analytical performance of electrochemical sensors for morphine detection reported by the 
literature (different sensors are listed from the oldest to that reported in this paper). 
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electrode surface 
solvent 
media 
electrochemical 
technique 
sensitivity 
LOD
*
 
 
ref 
   nA ppb
-1
 nA ppb
-1
mm
-2
 ppb  
Prussian Blue film KCl amperometry 0.0589 5.89  10
-4
 2.85  10
4
 24 
PEDOT based MIP KCl amperometry 0.322 3.22  10
-3
 5.71  10
4
 25 
MIP fixed in a 
PEDOT film 
KCl amperometry 0.0730 1.46  10
-3
 8.53  10
4
 26 
multiwalled carbon 
nanotubes 
PBS pH 7 amperometry 0.035 0.011 57 18 
hanging Hg drop 
Britton-
Robinson 
buffer (pH 
10) 
adsorptive striping 
voltammetry with 
differential pulse 
detection 
0.372  3.0 16 
Prussian Blue film 
KNO3 + 
acetate ions 
(pH 6) 
amperometry 0.273 0.0385 228 17 
gold nanoparticles PBS pH 7.0 cyclic voltammetry 1.19 0.033 60 27 
activated GC PBS pH 7.4 
adsorptive striping 
voltammetry with 
linear sweep 
detection 
0.251 0.0355 57 28 
ordered mesoporous 
carbon film 
PBS pH 7.0 
adsorptive striping 
voltammetry with 
linear sweep 
detection 
6.10  14.3 29 
Chemically reduced 
GO 
PBS pH 8.0 
differential pulse 
voltammetry 0.077 0.025 
128 15 
ZnO- carbon 
nanotubes 
composite in carbon 
paste 
PBS pH 8.0 
square wave 
voltammetry 
0.0529  17.1 30 
hydrophilic 
ionic liquid – NiO –  
carbon nanotube 
composite 
PBS pH 7.0 
square wave 
voltammetry 
0.176  2.9 31 
electrochemically 
reduced multiwalled 
carbon nanotube 
and graphene oxide 
composite 
PBS pH 4.5 
adsorptive striping 
voltammetry with 
linear sweep 
detection 
36.2 5.12 14 32 
Pt nanoparticles 
supported on porous 
silicon coating 
Britton-
Robinson 
buffer pH 6.0 
adsorptive striping 
with differential 
pulse voltammetry 
detection 
0.701 0.223 8.6 33 
Au nanoparticles 
and Co 
phthalocyanine in 
carbon paste 
Britton-
Robinson 
buffer pH 7.4 
differential pulse 
voltammetry 
0.057  1.6 34 
SnO2–Zn2SnO4 into 
multi-walled carbon 
nanotube paste 
PBS pH 6.0 
differential pulse 
voltammetry 
0.610  2.6 35 
MgFe2O4/graphite 
paste electrode 
modified with 
multi-walled carbon 
nanotubes 
PBS pH 7.0 
differential pulse 
voltammetry 
0.322  2.9 36 
EGO coating PBS at pH 7 
differential pulse 
voltammetry 
2.61 0.21 2.5 this paper 
* calculated as three times the standard deviation of the blank signal 
Table 1 
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